Sangamo enters into asset sale agreements with Lilly and Astellas

Click here to view

Additional information about the Chapter 11 reorganization and asset sales is available through Sangamo's noticing agent at https://www.veritaglobal.net/SangamoTherapeutics.

Presentation

Poster: Site-directed integration of large DNA sequences into endogenous sites in the human genome using engineered Modular Integrases (MINTS)

Download PDF